Genome-wide association analysis suggests novel loci for Hashimoto's thyroiditis.


Journal

Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594

Informations de publication

Date de publication:
May 2019
Historique:
received: 10 07 2018
accepted: 18 09 2018
pubmed: 5 10 2018
medline: 21 8 2019
entrez: 5 10 2018
Statut: ppublish

Résumé

Hashimoto's thyroiditis (HT) is the most common form of autoimmune thyroid diseases. Current knowledge of HT genetics is limited, and not a single genome-wide association study (GWAS) focusing exclusively on HT has been performed to date. In order to decipher genetic determinants of HT, we performed the first GWAS followed by replication in a total of 1443 individuals from Croatia. We performed association analysis in a discovery cohort comprising 405 cases and 433 controls. We followed up 13 independent signals (P < 10 We identified three variants suggestively associated with HT: rs12944194 located 206 kb from SDK2 (P = 1.8 × 10 Although discovered loci are implicated with susceptibility to HT for the first time, genomic regions harboring these loci exhibit good biological candidacy due to involvement in the regulation of the thyroid function and autoimmunity. Additionally, we observe genetic overlap between HT and several related traits, such as hypothyroidism, Graves' disease and TPOAb. Our study adds a new knowledge of underlying HT genetics and sets a firm basis for further research.

Identifiants

pubmed: 30284222
doi: 10.1007/s40618-018-0955-4
pii: 10.1007/s40618-018-0955-4
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Pagination

567-576

Subventions

Organisme : Hrvatska Zaklada za Znanost
ID : 4950
Organisme : Hrvatska Zaklada za Znanost
ID : 8875
Organisme : Hrvatska Zaklada za Znanost
ID : 1498
Organisme : Ministarstvo Obrazovanja, Znanosti i Sporta
ID : 216-1080315-0302
Organisme : Sixth Framework Programme
ID : LSHG-CT-2006-018947
Organisme : Seventh Framework Programme
ID : 313010

Références

Thyroid. 2004 Jul;14(7):510-20
pubmed: 15307940
J Clin Invest. 2007 Sep;117(9):2399-407
pubmed: 17694176
Int J Immunogenet. 2008 Apr;35(2):125-31
pubmed: 18279374
Am J Hum Genet. 2008 Jun;82(6):1270-80
pubmed: 18514160
Clin Endocrinol (Oxf). 2008 Nov;69(5):687-96
pubmed: 18673466
Croat Med J. 2009 Feb;50(1):4-6
pubmed: 19260138
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Am J Med. 2010 Feb;123(2):183.e1-9
pubmed: 20103030
Expert Rev Clin Immunol. 2007 Mar;3(2):217-23
pubmed: 20477110
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
J Hum Genet. 2011 Nov;56(11):772-8
pubmed: 21900946
Am J Hum Genet. 2011 Oct 7;89(4):529-42
pubmed: 21981779
Clin Endocrinol (Oxf). 2012 Apr;76(4):457-64
pubmed: 22168537
PLoS One. 2012;7(4):e34442
pubmed: 22493691
Curr Genomics. 2011 Dec;12(8):576-88
pubmed: 22654557
Nat Genet. 2012 Jun 17;44(7):821-4
pubmed: 22706312
Hum Mol Genet. 2012 Dec 1;21(23):5202-8
pubmed: 22922229
Genome Res. 2013 Jan;23(1):169-80
pubmed: 22936248
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
Nat Methods. 2013 Jan;10(1):5-6
pubmed: 23269371
PLoS Genet. 2013;9(1):e1003225
pubmed: 23382691
PLoS Genet. 2013;9(2):e1003266
pubmed: 23408906
Nat Rev Endocrinol. 2013 May;9(5):277-87
pubmed: 23529038
Genet Mol Res. 2013 Apr 26;12(2):1421-30
pubmed: 23661465
Nature. 2014 Feb 20;506(7488):376-81
pubmed: 24390342
Autoimmun Rev. 2014 Apr-May;13(4-5):391-7
pubmed: 24434360
J Clin Endocrinol Metab. 2014 Apr;99(4):E719-23
pubmed: 24471570
Nat Genet. 2014 Nov;46(11):1239-44
pubmed: 25261934
J Clin Endocrinol Metab. 2015 Feb;100(2):E319-24
pubmed: 25429627
Horm Metab Res. 2015 Sep;47(10):702-10
pubmed: 26361257
Nat Genet. 2016 Jul;48(7):709-17
pubmed: 27182965
Autoimmunity. 2016 Nov;49(7):480-485
pubmed: 27268232
Am J Hum Genet. 2017 Jan 5;100(1):40-50
pubmed: 27989323
Mediators Inflamm. 2017;2017:3916395
pubmed: 28133421
J Endocrinol Invest. 2017 Oct;40(10):1061-1067
pubmed: 28382505
Immunol Invest. 2017 Aug;46(6):625-638
pubmed: 28753406
Front Endocrinol (Lausanne). 2017 Jul 31;8:179
pubmed: 28824542
J Endocrinol Invest. 2018 Dec;41(12):1409-1416
pubmed: 29931474
Am J Med Genet B Neuropsychiatr Genet. 2018 Oct;177(7):641-657
pubmed: 30325587
N Engl J Med. 1996 Jul 11;335(2):99-107
pubmed: 8649497

Auteurs

L Brčić (L)

Department of Medical Biology, School of Medicine, University of Split, Šoltanska 2, 21000, Split, Croatia.

A Barić (A)

Department of Nuclear Medicine, University Hospital Split, Split, Croatia.

S Gračan (S)

Department of Nuclear Medicine, University Hospital Split, Split, Croatia.

M Brekalo (M)

Department of Nuclear Medicine, University Hospital Split, Split, Croatia.

D Kaličanin (D)

Department of Medical Biology, School of Medicine, University of Split, Šoltanska 2, 21000, Split, Croatia.

I Gunjača (I)

Department of Medical Biology, School of Medicine, University of Split, Šoltanska 2, 21000, Split, Croatia.

V Torlak Lovrić (V)

Department of Nuclear Medicine, University Hospital Split, Split, Croatia.

S Tokić (S)

Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Osijek, Osijek, Croatia.

M Radman (M)

Department of Nuclear Medicine, University Hospital Split, Split, Croatia.

V Škrabić (V)

Department of Pediatrics, University Hospital Split, Split, Croatia.

A Miljković (A)

Department of Public Health, School of Medicine, University of Split, Split, Croatia.

I Kolčić (I)

Department of Public Health, School of Medicine, University of Split, Split, Croatia.

M Štefanić (M)

Department of Nuclear Medicine and Oncology, Faculty of Medicine, University of Osijek, Osijek, Croatia.

L Glavaš-Obrovac (L)

Department of Medical Chemistry, Biochemistry and Clinical Chemistry, Faculty of Medicine, University of Osijek, Osijek, Croatia.

D Lessel (D)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

O Polašek (O)

Department of Public Health, School of Medicine, University of Split, Split, Croatia.

T Zemunik (T)

Department of Medical Biology, School of Medicine, University of Split, Šoltanska 2, 21000, Split, Croatia.

M Barbalić (M)

Department of Medical Biology, School of Medicine, University of Split, Šoltanska 2, 21000, Split, Croatia.

A Punda (A)

Department of Nuclear Medicine, University Hospital Split, Split, Croatia.

V Boraska Perica (V)

Department of Medical Biology, School of Medicine, University of Split, Šoltanska 2, 21000, Split, Croatia. vboraska@mefst.hr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH